Vontobel Holding Ltd.

Position in BBIO — BridgeBio Pharma, Inc.

CIK 1588340 ZURICH, V8

Position in BBIO

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$2,633,836

+$1,306,662 QoQ

Shares Held

35,363

+97.9% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#184

of 472 holders

Holding Since

Dec 2022

11 quarters on record

Voting authority Sole 25% Shared 0% None 75%

Healthcare · as of Jun 30, 2026

Vontobel Holding Ltd. holds $98,796,822 across 44 Biotechnology names. BBIO ranks #6 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	81,525	$40,495,910
2	REGN	Regeneron Pharmaceuticals, Inc.	33,169	$20,682,197
3	MRNA	Moderna, Inc.	87,541	$6,130,496
4	BNTX	BioNTech SE	61,238	$5,698,195
5	ARQT	Arcutis Biotherapeutics, Inc.	153,242	$4,018,005
6	BBIO	BridgeBio Pharma, Inc. This page	35,363	$2,633,836
7	TARS	Tarsus Pharmaceuticals, Inc.	40,000	$2,517,600
8	SLS	SELLAS Life Sciences Group, Inc.	146,762	$2,166,207

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,633,836	35,363	+97.9%	Shares	Defined	2026-08-03
2026-03-31	$1,327,174	17,872	-6.2%	Shares	Defined	2026-05-08
2025-12-31	$1,458,052	19,062	+82.6%	Shares	Defined	2026-02-13
2025-09-30	$542,357	10,442	+6.2%	Shares	Defined	2025-10-15
2025-06-30	$424,459	9,830	-67.5%	Shares	Defined	2025-07-23
2024-03-31	$934,278	30,216	-1.9%	Shares	Defined	2024-05-10
2023-12-31	$1,243,840	30,811	-53.6%	Shares	Defined	2024-06-04
2023-09-30	$1,749,834	66,357	-1.8%	Shares	Defined	2024-06-04
2023-06-30	$1,162,014	67,559	-27.1%	Shares	Defined	2024-06-04
2023-03-31	$1,537,297	92,720	-12.2%	Shares	Defined	2024-06-04
2022-12-31	$804,504	105,578	—	Shares	Defined	2023-02-14
No filing history on record for this holder in this stock.